Finzati - Logo
COSM logo

Cosmos Health Inc.

COSM • Medical - Pharmaceuticals
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$11.57M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:18 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$11.57M
52W Range0.16 - 1.32
Beta4.17
Gross Margin12.10%
Oper. Margin-25.34%
Profit Margin-29.33%
Debt/Eq1.08
Current Ratio1.00
Quick Ratio0.85
Volume4.24M

Investment DNA

How strong this company looks for long-term investors

38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
43/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/23/2010
Industry: Medical - Pharmaceuticals
P/B i: 0.82
Debt / Equity i: 1.08
Operating Margin: -25.34%
Net Margin: -29.33%
ROE i: -
ROIC: -

Financial Health

Score9 / 20
Debt / Equity: 1.08
Current Ratio: 1.00
Quick Ratio: 0.85
Status: Moderate

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Siokas Grigorios
Transaction: 07/30/2026
BUY
Change
+349,825
Price
$0.20
Filing
07/31/2026
Type
BUY
Siokas Grigorios
Transaction: 07/29/2026
BUY
Change
+766,284
Price
$0.18
Filing
07/30/2026
Type
BUY
Terzis Georgios
Transaction: 07/29/2026
BUY
Change
+328,407
Price
$0.18
Filing
07/30/2026
Type
BUY